For employers and insurers, the "initial question" was whether to cover GLP-1s for obesity, said Virta CEO Sami Inkinen
The contributing factors include: Facial fat loss : Weight loss affects fat throughout the body, including the face, leading to a loss of volume and support under the skin
But here is the counterpoint: Kaiser's data actually shows that members who go through the program before starting a GLP-1 have better long-term outcomes
5.Certification: MSDS,HALAL,COA,IFRA,ISO9001, ISO22000,26 Aller gens , etc
If you go into this expecting a Hollywood transformation in ten days, you are going to be disappointed
Preventive and treatment measures:Monitoring heart rate changes: During the use of GLP-1, patients should regularly monitor heart rate changes, promptly detect heart rate abnormalities, and take corresponding measures.Symptomatic treatment: For patients with significant increase in heart rate, appropriate use of heart rate regulating drugs (such as beta blockers) can be administered under the guidance of a doctor for symptomatic treatment.Blood pressure changes: The effect of GLP-1 receptor agonists on blood pressure is still controversial
